We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The British multinational GlaxoSmithKline has announced the closure of its facilities in Bangladesh after more than six decades of operation in the densely populated South Asian country.